Tiziana Life Sciences Ltd. Common Shares Share Price
NASDAQ: TLSAHealthcare
Live Tiziana Life Sciences Ltd. Common Shares Share Price Chart
O H L
Tiziana Life Sciences Ltd. Common Shares Performance Overview
Days Range
▼
$0.94Low
$0.95High
Markets Today
| Previous Close | $0.97 |
|---|---|
| Open | $0.95 |
| Volume | 72,354 |
| Day's Range | $0.94 - $0.95 |
| 52W Range | $0.76 - $2.35 |
| Market Cap | $98.00 M |
Historical Performance
| 1M Returns | -13.39 |
|---|---|
| 3M Returns | -16.38 |
| 6M Returns | -23.02 |
| 1Y Returns | -45.51 |
| 5Y Returns | -42.94 |
| 10Y Returns | NA |
Tiziana Life Sciences Ltd. Common Shares Fundamentals
| Market Cap | $98.00 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -9.24 |
| EPS TTM | $-0.16 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1784.67 |
| EBITDA | $-21.12 M |
| Profit Margin | N/A |
| Market Cap | $98.00 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -9.24 |
| EPS TTM | $-0.16 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1784.67 |
| EBITDA | $-21.12 M |
| Profit Margin | N/A |
Tiziana Life Sciences Ltd. Common Shares Profit & Loss
Quarterly
| Total Revenue + |
| Gross Profit + |
| Operating Income |
| EBITDA |
| Interest Expense |
| Depreciation |
| Income Before Tax |
| Income Tax Expense |
| Net Income + |
| Net Profit Margin |
Tiziana Life Sciences Ltd. Common Shares Financials Balance Sheet In USD
Quarterly
| Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|
| Share Capital | $97.00 K | $102.00 K | $102.00 K | $103.00 K | $111.00 K | $121.00 K |
| Reserve & Surplus | -$79.23 M | -$107.61 M | -$119.39 M | -$133.68 M | -$146.54 M | -$164.91 M |
| Non-Current Liabilities | $290.00 K | $0 | $243.00 K | $109.00 K | $0 | $234.00 K |
| Current Liabilities | $7.98 M | $7.55 M | $6.66 M | $6.54 M | $7.35 M | $11.21 M |
| Total Liabilities | $8.27 M | $7.55 M | $6.91 M | $6.65 M | $7.35 M | $11.44 M |
| Fixed Assets | $123.00 K | $147.00 K | $17.00 K | $10.00 K | $16.00 K | $26.00 K |
| Current Assets | $70.18 M | $48.68 M | $24.28 M | $7.34 M | $7.51 M | $8.55 M |
| Total Assets | $70.66 M | $48.83 M | $26.48 M | $12.18 M | $11.28 M | $11.49 M |
Tiziana Life Sciences Ltd. Common Shares Cash Flow
Quarterly
| Net Income |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
| Change in Cash |
Tiziana Life Sciences Ltd. Common Shares Return Calculator
The Tiziana Life Sciences Ltd. Common Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$5,471
Invested Amount$10,000
Est. Returns$-4,529
About Tiziana Life Sciences Ltd. Common Shares
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.
Popular Stocks
FAQs
What is the share price of Tiziana Life Sciences Ltd. Common Shares today?
Tiziana Life Sciences Ltd. Common Shares (TLSA) share price as of September 18, 2026 is $0.93. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Tiziana Life Sciences Ltd. Common Shares?
Yes, Indian Investors can invest in the Tiziana Life Sciences Ltd. Common Shares (TLSA) Share by opening an international trading account with Angel One.
How can I purchase Tiziana Life Sciences Ltd. Common Shares shares in India?
Purchasing Tiziana Life Sciences Ltd. Common Shares (TLSA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Tiziana Life Sciences Ltd. Common Shares (TLSA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Tiziana Life Sciences Ltd. Common Shares?
Yes, you can purchase fractional shares of Tiziana Life Sciences Ltd. Common Shares (TLSA) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Tiziana Life Sciences Ltd. Common Shares?
The market capitalization of Tiziana Life Sciences Ltd. Common Shares on September 18, 2026, is $98.00 M.
In which sector Tiziana Life Sciences Ltd. Common Shares belongs?
Tiziana Life Sciences Ltd. Common Shares operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Tiziana Life Sciences Ltd. Common Shares stocks?
In order to invest in Tiziana Life Sciences Ltd. Common Shares (TLSA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
